Home › Cardiovascular Disease › California › Concord
Cardiovascular Disease clinical trials in Concord, CA
4 studies for Cardiovascular Disease are looking for participants at sites in and around Concord (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- John Muir Medical Center - Concord Campus, Concord
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- John Muir Physician Network Clinical Research Center, Concord
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Walnut Creek · 5 mi away
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- Diablo Clinical Research, Walnut Creek · 5 mi away
Cardiovascular Disease trials in other cities
- Boston, MA37 studies
- New York City, NY33 studies
- Washington, DC28 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Cleveland, OH22 studies
- Atlanta, GA22 studies
- Chicago, IL21 studies
- Philadelphia, PA21 studies
- Pittsburgh, PA20 studies
- St. Louis, MO20 studies
- Nashville, TN18 studies
Other studies in Concord
- Obesity18 studies
- Overweight16 studies
- Non-Small Cell Lung Cancer14 studies
- Major Depressive Disorder12 studies
- Type 2 Diabetes10 studies
- Breast Cancer9 studies
- Lung Cancer9 studies
- Migraine8 studies
- Cancer (all types)7 studies
- Depression6 studies
- Prostate Cancer6 studies
- Diabetes5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.